Anti Phospholipid IgG Testing in Lahore at Lahore PCR Lab

Anti Phospholipid IgG at Lahore PCR Lab

The Anti Phospholipid IgG test is a highly specialized immunological assay designed to detect and quantify immunoglobulin G (IgG) autoantibodies directed against phospholipids and phospholipid-binding proteins in the blood. Phospholipids are essential lipid molecules that form the structural foundation of all cell membranes, including those of blood vessels and blood cells. When the immune system mistakenly identifies these normal components as foreign, it produces antiphospholipid antibodies (aPL). These autoantibodies interfere with normal coagulation pathways, significantly increasing the risk of inappropriate blood clot formation (thrombosis) in both arteries and veins, as well as causing severe obstetric complications.

At Lahore PCR Lab, this diagnostic evaluation is performed using advanced Enzyme-Linked Immunosorbent Assay (ELISA) or Chemiluminescent Immunoassay (CLIA) technologies. These state-of-the-art platforms allow for the highly sensitive and specific detection of IgG antibodies targeting cardiolipin and beta-2 glycoprotein I. Evaluating the IgG subclass is of paramount clinical importance, as IgG antibodies are more strongly associated with clinical events like thrombosis and pregnancy loss than other subclasses such as IgM or IgA. The diagnostic value of this test lies in its ability to confirm or rule out Antiphospholipid Syndrome (APS), also known as Hughes Syndrome, which is a leading cause of acquired hypercoagulability and recurrent miscarriage.

Identifying these antibodies early enables clinicians—including rheumatologists, hematologists, and obstetricians—to implement targeted therapeutic interventions, such as anticoagulant or antiplatelet regimens. This proactive clinical approach significantly reduces the risk of life-threatening events like stroke, pulmonary embolism, deep vein thrombosis, and placental insufficiency, ultimately improving patient outcomes and safeguarding maternal and fetal health.

Clinical Procedure: What to Expect

Patient Preparation

• No Fasting Required: Patients undergoing the Anti Phospholipid IgG test do not need to fast. You may eat and drink normally prior to your blood draw.
• Medication Disclosure: It is critical to inform your physician and the laboratory staff at Lahore PCR Lab about all medications you are currently taking, particularly anticoagulants (such as warfarin, heparin, or direct oral anticoagulants) and antiplatelet therapies (like aspirin), as these can influence overall coagulation profiles.
• Hydration: Drinking plenty of water before the procedure is highly recommended, as adequate hydration makes veins more prominent and facilitates a smoother venipuncture process.
• Comfortable Clothing: Wear loose-fitting clothing or garments with sleeves that can be easily rolled up above the elbow to allow clear access to the blood collection site.

During the Procedure

The blood collection process at Lahore PCR Lab is quick, safe, and performed under strict aseptic conditions. You will be seated comfortably in a specialized blood collection chair. A qualified phlebotomist will inspect your arm to locate a suitable vein, typically in the inner elbow area. Once a vein is selected, the skin is thoroughly cleansed with an antiseptic alcohol swab to eliminate surface bacteria.

A sterile tourniquet is applied to your upper arm to increase venous pressure, making the vein easier to access. Using a sterile, single-use needle, the phlebotomist will gently puncture the vein and collect a small sample of blood into a serum separator tube. You may feel a brief, mild pinch as the needle is inserted. After the required volume is collected, the needle is carefully withdrawn, and immediate pressure is applied to the site with a sterile cotton ball to prevent bruising. An adhesive bandage is then applied, and the entire procedure is completed in less than five minutes.

When is an Anti Phospholipid IgG Test Performed?

Evaluating Antiphospholipid Syndrome (APS)

Physicians request this test when they suspect a patient has Antiphospholipid Syndrome, a systemic autoimmune disorder characterized by recurrent vascular thrombosis or specific pregnancy-related complications. The detection of IgG-class antiphospholipid antibodies is a core laboratory criterion for the international classification and diagnosis of APS, helping clinicians differentiate autoimmune-mediated clotting disorders from other inherited thrombophilias.

Investigating Recurrent Miscarriages and Pregnancy Complications

This test is routinely performed for women who have experienced unexplained recurrent pregnancy losses, defined as three or more consecutive spontaneous abortions before the 10th week of gestation, or one or more unexplained fetal deaths at or beyond the 10th week of pregnancy. The presence of IgG antibodies can lead to placental thrombosis, restricted fetal growth, or early-onset preeclampsia, making this test vital for obstetric risk assessment.

Investigating Unexplained Blood Clots (Thrombosis)

When a patient presents with an unexplained deep vein thrombosis (DVT) in the legs, a pulmonary embolism (PE) in the lungs, or an arterial clot without traditional cardiovascular risk factors, clinicians order this test. Identifying an underlying autoimmune cause for hypercoagulability is essential for determining the appropriate duration and intensity of long-term anticoagulant therapy.

Monitoring Systemic Lupus Erythematosus (SLE) and Autoimmune Diseases

Patients diagnosed with Systemic Lupus Erythematosus (SLE) or other connective tissue diseases are frequently screened for antiphospholipid antibodies. Approximately 30% to 40% of patients with lupus test positive for these antibodies. Monitoring their levels helps assess the patient's overall risk for secondary Antiphospholipid Syndrome and subsequent thrombotic complications.

Evaluating Unexplained Stroke or TIA in Young Adults

An Anti Phospholipid IgG test is indicated for young individuals (under the age of 50) who experience an unexplained ischemic stroke or transient ischemic attack (TIA). Because conventional stroke risk factors like atherosclerosis are less common in younger populations, ruling out autoimmune-mediated arterial thrombosis is a critical step in the diagnostic workup.

What Does an Anti Phospholipid IgG Test Detect?

The Anti Phospholipid IgG test evaluates several immunological parameters and clinical risks, detecting:

• The presence of IgG autoantibodies targeting cardiolipin in the blood serum.
• The presence of IgG autoantibodies targeting beta-2 glycoprotein I.
• Quantitative titers of anti-cardiolipin IgG antibodies, measured in GPL units.
• Quantitative titers of anti-beta-2 glycoprotein I IgG antibodies, measured in U/mL.
• Low-positive or borderline antibody levels that may indicate transient autoimmune responses.
• Moderate-to-high positive antibody levels strongly associated with clinical Antiphospholipid Syndrome.
• Negative antibody status, helping rule out IgG-mediated autoimmune hypercoagulability.
• Co-existence of multiple antiphospholipid antibodies, indicating a higher risk profile (triple positivity).
• Autoimmune-mediated risks for deep vein thrombosis (DVT).
• Autoimmune-mediated risks for acute pulmonary embolism (PE).
• Potential causes of unexplained arterial thrombosis, including premature myocardial infarction.
• Potential causes of unexplained ischemic stroke or TIA in young adults.
• Underlying causes of recurrent first-trimester pregnancy losses.
• Underlying causes of late-term unexplained fetal demise.
• Risk factors for severe, early-onset preeclampsia occurring before 34 weeks of gestation.
• Risk factors for placental insufficiency and intrauterine growth restriction (IUGR).
• Secondary Antiphospholipid Syndrome associated with Systemic Lupus Erythematosus (SLE).
• Secondary Antiphospholipid Syndrome associated with rheumatoid arthritis or Sjogren's syndrome.
• Autoantibody profiles associated with livedo reticularis (mottled, purplish skin discoloration).
• Risks of autoimmune-mediated thrombocytopenia (low platelet count).
• Risks of autoimmune hemolytic anemia.
• Potential causes of cardiac valvular thickening or vegetations (Libman-Sacks endocarditis).
• Transiently elevated antibodies caused by recent viral, bacterial, or parasitic infections.
• Drug-induced antiphospholipid antibodies resulting from specific medications.
• Persistent antibody positivity when confirmed by a repeat test performed 12 weeks later.

Turnaround Time and Report Access at Lahore PCR Lab

Lahore PCR Lab utilizes advanced, fully automated immunoassay analyzers to process immunological tests with the highest degree of precision and speed. The typical turnaround time for the Anti Phospholipid IgG test is 24 to 48 hours from the time of sample collection. Once the analysis is complete, the results undergo a rigorous multi-stage validation process by our qualified clinical pathologists to ensure absolute accuracy.

Patients can access their diagnostic reports conveniently from the comfort of their homes. Lahore PCR Lab provides digital report access through a secure online patient portal, as well as automated SMS and WhatsApp notifications containing direct download links. Physical copies of the reports can also be collected from the main laboratory reception or any of our designated collection centers across Lahore, Pakistan.

Anti Phospholipid IgG Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Anti-Cardiolipin IgG	Negative (< 10 GPL)	Positive (> 40 GPL), indicating high risk of thrombosis or APS.
Anti-Beta-2 Glycoprotein I IgG	Negative (< 10 U/mL)	Positive (> 10 U/mL), associated with autoimmune hypercoagulability.
Lupus Anticoagulant Co-evaluation	Not detected (Normal clotting times)	Detected (Prolonged clotting times not corrected by normal plasma).
Platelet Count Correlation	Normal (150,000 – 450,000 /mcL)	Thrombocytopenia (< 150,000 /mcL), common in secondary APS.
aPTT (Coagulation Screen)	Normal range (typically 25-35 seconds)	Prolonged aPTT, paradoxically associated with increased clotting risk in APS.
Pregnancy History Correlation	No history of unexplained fetal loss	Recurrent early miscarriages or late-term fetal demise.
Vascular History Correlation	No history of unexplained thrombosis	Documented episodes of DVT, PE, stroke, or arterial occlusion.
Repeat Testing (12-Week Interval)	Transient elevation resolved	Persistent positive titers, confirming clinical diagnosis of APS.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Lahore PCR Lab for Anti Phospholipid IgG?

• Experienced Healthcare Professionals: Our laboratory is led by highly qualified clinical pathologists and immunologists who oversee all testing procedures.
• Patient-Focused Care: We prioritize patient comfort, safety, and confidentiality, ensuring a seamless and stress-free diagnostic experience.
• Quality Diagnostic Services: Lahore PCR Lab utilizes state-of-the-art automated immunoassay platforms to deliver highly precise and reproducible results.
• Professional Reporting: Our reports are structured, clear, and easy to understand, providing clinicians with the exact quantitative data needed for diagnosis.
• Modern Diagnostic Approach: We strictly adhere to international diagnostic guidelines and classification criteria for autoimmune disorders.
• Comfortable Environment: Our collection centers across Lahore maintain the highest standards of hygiene, sterility, and patient comfort.
• Convenient Location: Strategically located in Lahore, Pakistan, our facilities are easily accessible for patients from all parts of the city.
• Commitment to Accurate Diagnosis: We implement rigorous internal and external quality control protocols to guarantee the clinical validity of every test.